1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"The Sephardic Foundation on Aging - Combating Social Isolation of Older Adults Grant" is currently closed and not accepting applications.
The Sephardic Foundation on Aging - Combating Social Isolation of Older Adults Grant is sponsored by The Sephardic Foundation on Aging. Supports programs and projects related to combating social isolation of older adults.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Organizations supporting older adults in combating social isolation. Confirm the full requirements in the official notice before applying.
The published deadline was April 23, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
The Sephardic Foundation on Aging - Combating Social Isolation of Older Adults Grant is funded by The Sephardic Foundation on Aging. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Seven research teams will run the first clinical trials aimed at extending human healthspan under ARPA-H PROSPR contracts worth up to $144M. The milestone-based contract model breaks every convention of federal biomedical funding.
Read articleARPA-H PROSPR program funds seven research teams up to $144M to develop the first clinical trials targeting biological aging itself, testing rapamycin analogs, semaglutide, and retrotransposon inhibitors.
Read articleARPA-H awarded $144M across 7 research teams to run the first clinical trials treating aging as a condition — not a disease. How PROSPR reshapes longevity funding and what grant seekers in biotech, academia, and health tech should know.
Read article